-- Corning Incorporated (NYSE: GLW), today announced its new Axygen® brand IMAG™ handheld magnetic beads separation devices. The Axygen brand magnetic separation devices (MSDs) revolutionize manual magnetic bead-based separation processes used in biological research, including nucleic acid purification and clean up, cell-based assays, and antibody and protein purification. The new IMAG MSDs can cut the total separation process, and labor by up to 50 percent. “The current process for magnetic separation has many limitations and is time- and labor- intensive, including multiple pipetting steps,” said Bassam El-Fahmawi, Ph.D., bioscience business manager, Axygen Inc., a Corning subsidiary. “Traditionally, MSDs are not optimized for manual use and most require electric-powered liquid handling systems. Our new IMAG MSDs, in tube or microplate formats, allow low-throughput Next-Generation Sequencing (NGS) users to prepare NGS libraries as easily and conveniently as automation users, without making a large capital investment.” Features and benefits of the new Axygen brand IMAG MSDs include:

Availability in both single-tube or 96-well microplate formats

Increased operational efficiency

Strong magnets can cut separation time to less than 30 seconds

Saves time and money

Manual operation with low- to high-throughput capabilities.

Corning is also introducing a full line of Axygen magnetic bead-based kits which can make the NGS library preparation process more efficient. The AxyPrep™ Mag PCR Normalizer Kit, for example, utilizes a paramagnetic bead-based purification system for polymerase chain reaction (PCR) clean-up and allows researchers to skip the time-consuming quantification step. This can reduce the typical seven-hour process by up to one hour. Through acquisition and ongoing R&D investment, Corning now offers a more comprehensive range of premium, innovative laboratory products and solutions for a wide spectrum of life science applications. Corning’s trusted, quality brands, backed by technical expertise, provide researchers with better ways to advance their research from the beginning of their process to the end. The family of brands includes Corning®, PYREX®, Costar®, Axygen, Gosselin™ and Corning cellgro®.

Corning Life Sciences brings new and innovative laboratory technologies to researchers worldwide and helps customers succeed by providing innovative, high-quality products and services in the areas of polymer science, biochemistry and molecular biology, glass melting and forming, surface modification, and characterization science.

To learn more about IMAG handheld magnetic beads separation devices or the AxyPrep MagPCR Normalizer Kits, please contact a customer service representative at 1-510-494-8900, or visit www.corning.com/lifesciences.

Forward-Looking and Cautionary StatementsThis press release contains “forward-looking statements” (within the meaning of the Private Securities Litigation Reform Act of 1995), which are based on current expectations and assumptions about Corning’s financial results and business operations, that involve substantial risks and uncertainties that could cause actual results to differ materially. These risks and uncertainties include: the effect of global political, economic and business conditions; conditions in the financial and credit markets; currency fluctuations; tax rates; product demand and industry capacity; competition; reliance on a concentrated customer base; manufacturing efficiencies; cost reductions; availability of critical components and materials; new product commercialization; pricing fluctuations and changes in the mix of sales between premium and non-premium products; new plant start-up or restructuring costs; possible disruption in commercial activities due to terrorist activity, armed conflict, political or financial instability, natural disasters, adverse weather conditions, or major health concerns; adequacy of insurance; equity company activities; acquisition and divestiture activities; the level of excess or obsolete inventory; the rate of technology change; the ability to enforce patents; product and components performance issues; retention of key personnel; stock price fluctuations; and adverse litigation or regulatory developments. These and other risk factors are detailed in Corning’s filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the day that they are made, and Corning undertakes no obligation to update them in light of new information or future events.

About Corning IncorporatedCorning Incorporated (www.corning.com) is the world leader in specialty glass and ceramics. Drawing on more than 160 years of materials science and process engineering knowledge, Corning creates and makes keystone components that enable high-technology systems for consumer electronics, mobile emissions control, telecommunications and life sciences. Our products include glass substrates for LCD televisions, computer monitors and laptops; ceramic substrates and filters for mobile emission control systems; optical fiber, cable, hardware & equipment for telecommunications networks; optical biosensors for drug discovery; and other advanced optics and specialty glass solutions for a number of industries including semiconductor, aerospace, defense, astronomy, and metrology.